Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF OverviewAmplify ETF Trust - Amplify Treatments, Testing and Advancements ETF EBIT
EBIT (Earnings Before Interest and Taxes) analysis for GERM.
Quarterly EBIT
-$30.95M
↓ 155.89% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
$153.03M
↓ 62.47% YoY
Trailing 12 months ending Mar 31, 2026